In vivo efficacy of trovafloxacin (CP-99,217), a new quinolone, in experimental intra-abdominal abscesses caused by Bacteroides fragilis and Escherichia coli.

The efficacy of trovafloxacin in treating Bacteroides fragilis and Escherichia coli infections was investigated and compared to the efficacy of combined clindamycin and gentamicin therapy in an experimental model of intra-abdominal abscesses in rats. Rats were treated with different doses of CP-116,...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Thadepalli, H, Reddy, U, Chuah, S K, Thadepalli, F, Malilay, C, Polzer, R J, Hanna, N, Esfandiari, A, Brown, P, Gollapudi, S
Format: Artigo
Langue:Inglês
Publié: 1997
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC163755/
https://ncbi.nlm.nih.gov/pubmed/9055997
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires